PÓSTERS BECADOS (ASBMR)
MARKERS OF MATURATION AND OPG/RANKL SYSTEM IN HUMAN PRIMARY OSTEOBLASTS CULTURES
M. Giner, M.J. Montoya, M.A. Vázquez, R.M. Moruno, M.J. Miranda y R. Pérez-Cano.
Bone Metabolism Unit, Internal Medicine, University Hospital Virgen Macarena. Seville, Spain.
C-TERMINAL PARATHYROID HORMONE-RELATED PROTEIN (107-139) INHIBITS APOPTOSIS THROUGH VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 IN HUMAN OSTEOBLASTIC CELLS
V. Alonso1, A.R. de Gortázar1, R. Berruguete2, P. Esbrit1 and M.V. Álvarez-Arroyo2.
1Bone and Mineral Metabolism Laboratory and 2Fundación Jiménez Díaz-UTE (Capio Group). MADRID, Spain
CHARACTERIZATION OF AN EXPERIMENTAL MODEL OF OSTEOPOROSIS IN RABBITS INDUCED BY COMBINED OVARIECTOMY AND CORTICOSTEROIDS
S. Castañeda1, E. Calvo2, R. Largo2, C. de la Piedra2, M. Díaz-Curiel2, M. Bellido2 y G. Herrero-Beaumont2.
1Rheumatology Unit, 2Bone and Mineral Metabolism Laboratory. Hospital de la Princesa, Fundación Jiménez Díaz, Madrid, Spain.
A HIGHT CTx LEVEL IS ASSOCIATED WITH A HIGHER RATE OF BONE LOSS IN EARLY POSTMENOPAUSAL WOMEN
L. Navarro2, J.A. Blázquez1, M. Cháfer2, F. Mateos1, E. Almar3, J. del Pino4.
1Departments of Internal Medicine1 and Clinical Chemistry. 2University Hospital, Albacete, Spain. 3Epidemiology, Primary Care, Albacete, Spain. 4Department of Medicine. University Hospital, Salamanca, Spain.
Nuestro agradecimiento a Lilly, Roche/GSK, Sanofi-Aventis/Almirall y Nycomed por hacer viable esta iniciativa.